OptiRiMoxTB – An international pragmatic trial with Optimised dose of Rifampicin and Moxifloxacin for the treatment of drug susceptible pulmonary tuberculosis (TB) The OptiRiMoxTB clinical trial is part of SimpliciTB programme, which includes an international...
STAND (Shortening Treatment by Advancing Novel Drugs) Trial The Infection and Global Health Division are committed to finding new and better treatment for tuberculosis (TB) through high quality clinical trials. Our work continues to test regimens including the novel...
Some of these cookies are essential, while others help us to improve your experience.
For more information visit our cookie notice.
Necessary cookies
Necessary cookies enable core functionality. The website cannot function properly without these cookies which can only be disabled by changing your browser preferences.
These cookies allow us to count visits and traffic sources, so we can measure and improve the performance of our site.
Warning: some cookies require your attention
Consent for the following cookies could not be automatically revoked. Please follow the link(s) below to opt out manually.
These cookies are set through our site by third-party provided features. They may be used by those companies to build a profile of your interests and show you relevant ads on other sites.
Warning: some cookies require your attention
Consent for the following cookies could not be automatically revoked. Please follow the link(s) below to opt out manually.
